FDA Appoints New Head of Medical Devices
Exposure to Inorganic Arsenic in Drinking Water Increases Cardiovascular Risk
Risk for ischemic heart disease elevated even at exposure levels below the current regulatory limit of 10 µg/L
Adult Hypertension Prevalence 47.7 Percent From August 2021 to August 2023
Hypertension increased with age, from 23.4 percent for those aged 18 to 39 years to 71.6 percent for those aged 60 years and older
Poor Cardiovascular Health Linked to Composite of Poor Brain Health
Individuals with poor or intermediate cardiovascular health have increased risk for composite of stroke, dementia, late-life depression
High-Volume Centers Do Not Mitigate Heart Transplant Survival Disparity
The most socioeconomically deprived recipients show inferior survival at three and five years after transplantation
Early Rheumatoid Arthritis Tied to Hypertension
Highest risk seen in older patients with traditional cardiovascular risk factors
Varying Dialysate Calcium Dosage Not Tied to Differences in All-Cause, Cardiovascular Mortality
Findings seen for 1.50 versus 1.25 mmol/L in patients undergoing hemodialysis
Standing More During the Day Does Not Cut Cardiovascular Risk
In fact, standing more than two hours a day may be tied to higher risk for circulatory issues
Risk for Most Cardiovascular Events Reduced After COVID-19 Vaccination
Increased risk for myocarditis, pericarditis seen one to two weeks after COVID-19 mRNA vaccination
Substantial Mortality Benefits Expected From Optimal Medication Use for HFrEF
1,188,277 deaths could potentially be prevented over 12 months with optimal implementation of quadruple guideline-directed medical therapy
